Stock Symbol:

XOMA

Company Name:

XOMA Ltd.

Company Description:

XOMA Ltd., a biopharmaceutical company, engages in the discovery, development, and manufacture of therapeutic antibodies to treat inflammatory, autoimmune, infectious, and oncological diseases. The company receives royalties on products, such as LUCENTIS for the treatment of neovascular (wet) age-related macular degeneration; and CIMZIA for the treatment of rheumatoid arthritis and Crohn's disease.

Investment Sector:

Biotechnology and Drugs

Predicted Split Months:

M-J-S-D

Stock Exchange:

NASDAQ

Predicted Split Price:

$7.00

Predicted Split Ratio:

5 for 4

5 Day Performance After Split:

0.1%

Prior Stock Splits:

1

Stock Split History:

Aug 18, 2010 [1:15]

Split Predictions Are Based Upon Historical Stock Market Data And Sector Trends. This Data Is For Educational Purposes Only.